Jul 27, 2022 / 01:00PM GMT
Javier Lopez-Belmonte Encina - Laboratorios Farmaceuticos Rovi, S.A. - First Deputy Chairman & CFO
Good afternoon, and welcome, everybody, to this first half results vital meeting which will start in a moment. This is Javier Lopez-Belmonte, Rovi's Vice President and Chief Financial Officer. Please let me introduce Rovi's attendees today, Juan Lopez-Belmonte, Chairman and CEO; Marta Campos, Head of Investor Relations; and myself.
At the end of the presentation, a question-and-answer session will commence. If you want to ask any questions during the presentation, please do not hesitate to send them through the question button on the platform. Thank you for your presence here today. And let's now start the presentation. I Mr. Juan Lopez-Belmonte the floor.
Juan Lopez-Belmonte Encina - Laboratorios Farmaceuticos Rovi, S.A. - President, CEO & Director
Thank you, Javier, and welcome to everybody. I'm happy to present our first half 2022 results. In these exceptional times, robust performance during the period has been
Q2 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript
Jul 27, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers